For decades, we thought that psychedelics only affected the mind.
Today, science is beginning to ask itself a much bigger question:
Could they also help the body recover?
And one of the most interesting questions arises in oncology.
The problem caused by chemotherapy
Chemotherapy saves millions of lives.
However, some of the drugs used to destroy tumor cells can also damage peripheral nerves.
This side effect is known as chemotherapy-induced peripheral neuropathy (CIPN).
Symptoms may include:
constant pain
tingling
loss of sensation
muscle weakness
difficulty walking or using one's hands
In many patients, these symptoms go away.
In other cases, they can last for years or even become permanent.
Currently, there are very few truly effective treatments for repairing this damage.
A discovery that changed the way we view cancer
Surgical oncologist Dr. Moran Amit, a researcher at MD Anderson Cancer Center, has spent years studying the relationship between tumors and the nervous system.
His work revealed something surprising:
Nerves aren't just bystanders.
Many tumors establish active communication with them and use nerve signals to promote their growth, invasion, and spread.
In other words:
The nervous system plays a much greater role in the biology of cancer than was thought a few years ago.
This discovery opened up new avenues of research into how to protect and regenerate nerves affected by both the tumor and certain treatments.
Where does psilocybin come into play?
Here is a hypothesis that is generating a lot of interest.
Various laboratory studies have shown that psilocybin and its active metabolite, psilocin, can stimulate processes related to neuroplasticity.
Experimental models have shown that they promote:
growth of new neural connections
dendritic spine formation
increase in factors related to neuronal regeneration
greater adaptability of the nervous system
That is why some researchers are asking:
If psilocybin promotes neural plasticity…
Could it one day help repair the nerve damage caused by chemotherapy?
What Science Says Today
The honest answer is:
We don't know yet.
So far:
There is strong evidence that psilocybin can induce neuroplastic changes in preclinical studies;
There are also clinical trials that show significant benefits for anxiety, depression, and emotional distress in cancer patients;
However, there are still no clinical studies demonstrating that psilocybin regenerates nerves damaged by chemotherapy in humans.
It is a promising scientific hypothesis.
Not a proven treatment.
What Might Be Ahead
Many researchers believe that psychedelics may have much broader medical applications than we imagined just a few years ago.
If future research confirms that they can promote nervous system repair, they could open up a new avenue for treating diseases for which there are currently very few treatment options.
But that answer can only come from well-designed clinical trials.
Science has only just begun to ask the question.
He's still looking for the answer.
